semaglutide fda label (Wegovy) Receives Expansion to Include Cardiovascular Risk Reduction FDA Approves Ozempic for Kidney

Our products meet label claim (meaning you can trust what you read on the label)

The chromatographic ion exchange resin is chosen depending on the specific GLP-1 peptide to be purified and the conditions employed, such as pH, buffer, ionic strength etc., which are known to the person skilled in the art (that is, typically, pH below the isoelectric point (pl) of the GLP-1 peptide for cation exchange resins and pH above pl of the GLP-1 peptide for anion exchange resins, a sufficient buffer strength to maintain the desired pH, and a sufficiently low ionic strength possibly induced by the salt concentration), and includes but is not limited to Sepharose resins, Sephadex resins, Streamline resins, and Source resins from Amersham-Pharmacia Biotech, HyperD resins, Trisacryl resins, and Spherosil resins from BioSepra, TSKgel resins and Toyopearl resins from TosoHaas, Fractogel EMD resins from Merck, Poros resins from Perseptive Biosystems, Macro-Prep resins from BioRAD, Express-ion resins from Whatman etc

Ibsen S, Schutt CE, Esener S

Prescribers who have patients who may qualify for the Bridge starting July 1 should contact their medical billing team or EHR vendor to understand the prior authorization workflow for Bridge claims, as it differs from standard Part D prior authorization

Constipation ranks among the top three complaints from GLP-1 medication users, affecting up to 24% of patients in clinical trials